Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Integrated Biopharma Inc (INBP)

Integrated Biopharma Inc (INBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023 ACCESSWIRE - Thu Nov 9, 2023

HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023.

INBP : 0.1906 (-0.16%)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023 ACCESSWIRE - Fri Sep 15, 2023

HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023.

INBP : 0.1906 (-0.16%)
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023 ACCESSWIRE - Thu May 11, 2023

HILLSIDE, NJ / ACCESSWIRE / May 11, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2023.

INBP : 0.1906 (-0.16%)
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022 ACCESSWIRE - Fri Feb 10, 2023

HILLSIDE, NJ / ACCESSWIRE / February 10, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2022.

INBP : 0.1906 (-0.16%)
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022 ACCESSWIRE - Thu Nov 10, 2022

HILLSIDE, NJ / ACCESSWIRE / November 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2022.

INBP : 0.1906 (-0.16%)
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022 ACCESSWIRE - Tue Sep 13, 2022

HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2022.

INBP : 0.1906 (-0.16%)
Integrated BioPharma Announces Change in Directors AccessWire - Tue Jun 21, 2022

HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Board...

INBP : 0.1906 (-0.16%)
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022 AccessWire - Thu May 12, 2022

HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the three-month...

INBP : 0.1906 (-0.16%)
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021 AccessWire - Thu Feb 10, 2022

HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the...

INBP : 0.1906 (-0.16%)
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021 AccessWire - Wed Nov 10, 2021

HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for the...

INBP : 0.1906 (-0.16%)

Barchart Exclusives

Stocks Set to Open Higher as Investors Await More Corporate Earnings and Fed Speak Barchart - 41 minutes ago
June S&P 500 E-Mini futures (ESM24) are up +0.24%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.18% this morning as market participants looked ahead to a fresh batch of corporate earnings reports and remarks from a host of Federal Reserve officials. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot